Osteoporosis is a common skeletal disorder characterized by deterioration of bone tissue in later life. The set of genetic factors contributing to osteoporosis is not completely specified. High-risk osteoporosis pedigrees were analyzed to identify genes that may confer susceptibility to disease.
INTRODUCTION
Osteoporosis is a common skeletal disorder characterized by deterioration of bone mineral density (BMD) and increased risk of fracture (1) . Identification of genetic factors that have a strong influence on disease could enhance screening and knowledge concerning biological pathways involved. Genome-wide association studies (GWAS) have identified over 500 common single nucleotide polymorphisms (SNPs) associated with BMD (2), revealing several relevant biological pathways including genes involved in WNT signaling, the RANK/RANKL/OPG pathway, and genes involved in endochondral ossification. GWAS studies have revealed that osteoporosis is highly polygenic. SNPs identified thus far are estimated to account for about 20% of trait variation (3), whereas overall heritability estimates for BMD are higher, ranging from 50 to 90% (4, 5) . The difference may in part be due to rare genetic variations whose effects are not typically detectable in GWAS. Family based designs present a complementary approach that may provide opportunities to discover rare, penetrant variants (6) .
Using a multi-generational pedigree resource, we performed exome sequencing on affectedrelative-pairs with a deficiency in BMD from 10 high-risk osteoporosis pedigrees to identify rare, coding variants that may be contributing to osteoporosis risk in these families. Analysis of this resource identified a rare coding variant in the MEGF6 (multiple epidermal growth factorlike protein 6, alternately known as EGFL3) gene that segregates to additional family members with osteoporosis. Computational and functional analyses indicate that the MEGF6 variant likely disrupts wildtype (WT) protein function and that zebrafish paralogues contribute to bone and cartilage formation in vivo.
RESULTS

Variant prioritization
To identify genes associated with osteoporosis, multigenerational pedigrees were identified in which near-cousin pairs as well as additional individuals were confirmed to have a diagnosis of osteoporosis (see Materials and Methods). Exome sequencing of affected near-cousin pairs in each of ten pedigrees identified a total of ~45K variants. Among these, 548 coding variants in 480 genes were rare (MAF<0.005 in EXAC browser (7)) and concordant between a sequenced pair of affected cousins. Restricting candidates to identity-by-descent (IBD) regions for sequenced pairs as identified by shared genomic segments (SGS) analysis (8) further limited the selection to 125 rare, shared candidate variants in 111 genes. A search of PubMed for each of the 111 genes to identify previous reported association to osteoporosis further limited selection to variants in 12 candidate genes. In a fourth filtering step, variants that were scored as 'damaging' by at least 8 of 10 in-silico pathogenicity prediction algorithms included in ANNOVAR variant annotations were retained, resulting in 3 candidate genes (MEGF6 (rs755467862), PAX8 (rs1269341622), and UMPS (rs777350640)).
Confirmation of candidate variants via segregation
Six additional carriers of the MEGF6 variant c.599 T>C; p.Cys200Tyr (rs755467862) were identified among 14 relatives of the index cousins that were assayed for the variant. Among the eight variant carriers identified in the pedigree, the sequenced index cousins as well as one relative had a physician-confirmed diagnosis of osteoporosis, four additional individuals had a physician confirmed diagnosis of osteopenia, and one individual was unaffected (screened in the 50th decade of life); four of the eight carriers had a medical history of bone fractures, and four had been treated previously for osteoporosis ( Figure 1 ). Of the remaining six assayed relatives that did not carry the variant, none had a physician-confirmed diagnosis of osteoporosis. The deidentified pedigree segregating rs755467862 is depicted in Figure 1 and had significant evidence of segregation to affected relatives (osteoporosis or osteopenia, RVsharing p=0.0011) after correcting for 3 candidate variants (α=0.05/3=0.017) (9) .
In silico functional evaluations of rs755467862
Variant rs755467862 is a non-synonymous variant substituting base T for C (c.599 T>C) in exon 5 that codes a Cysteine > Tyrosine amino acid substitution (p.Cys200Tyr). Population frequency has been estimated (MAF/number of alleles tested) as T=4e-5/243,578 (10) . Variant rs755467862 was predicted to be damaging by almost all of the functional prediction software included in Annovar (11), including Polyphen (12), LRT_pred (13), MutationTaster (14) , FATHMM (15), Radial_SVM (16), LR score (16), but not SIFT (17) . The GERP score for the variant is 5.0, indicating strong evidence for conservation of the reference allele across species (18) .
The candidate variant rs755467862 produces an amino acid substitution Cys200Tyr in the second EGF-like calcium binding domain of MEGF6. As MEGF6 is a large protein of 1541 amino acids, the entire protein is not amenable to existing 3D structure prediction methods. I-TASSER software (19) predicted the structure of the affected EGF-like calcium binding domain (residues 161-201) for both wild type and variant amino acid sequences, resulting in two distinct candidate structures for the wild type and five structures for variant proteins. From the ten possible comparisons, five (50%) showed substantial differences between the wild type and variant predicted structures. An example of this is presented in Figure 2 where it is apparent that the amino acid substitution disrupts a disulfide bond between residues 187 and 200 in the second EGF-like calcium-binding domain, where a helix is formed instead of an open loop. Similar behavior was observed in the other comparisons. The main structure of EGF-like domains is a two-stranded β-sheet followed by a loop where the calcium ion binds (20) . The collapse of this loop may eliminate this calcium binding site in MEGF6, which may decrease, or even eliminate, the functionality of the protein.
Protein interaction network
As variation in MEGF6 expression or function has not been shown to be associated with bone development or homeostasis, we analyzed whether its protein product might have potential interactions with proteins more directly related to bone formation. Analysis with the STRING database tool (21) showed MEGF6 is related to pathways involved in various biological processes ( Figure 3A ) including angiogenesis (EMILIN1, a protein involved in vessel assembly (22) , and most notably, osteoporosis (ZBTB40 (23, 24) ). Figure 3B contains a STRING graph recentered on ZBTB40 that shows connections with WNT16, which has been previously associated with BMD (25).
Analysis of zebrafish megf6a and megf6b gene expression and function
Our analyses indicated that a coding variant of MEGF6 segregated with the occurrence of osteoporosis, that the variant was likely to be damaging to gene function, and that there was support for a functional link between the protein product of MEGF6 and pathways known to contribute to osteoporosis. To uncover biological functions of MEGF6, we examined the consequences of complete loss of gene function in the zebrafish.
The zebrafish genome contains two megf6 paralogues, megf6a and megf6b, which are orthologous to the single human MEGF6 gene. Each orthologue has similar degree of identity (megf6a -56% and megf6b -54%) and similarity (megf6a -68% and megf6b -64%) to the human orthologue. The expression patterns of megf6a and megf6b were determined by wholemount in situ hybridization (WISH) at 24, 36, and 48 hours post fertilization (hpf). At 24 hpf megf6a is broadly expressed in the head (Supplemental Figure 1A) . At 36 hpf it is localized to the apical ectodermal ridge (AER) of the pectoral fin (Supplemental Figure 1B) , the atrioventricular canal (Supplemental Figure 1C) , and the notochord (Supplemental Figure 1D) , and it is broadly expressed in the head. megf6b is expressed in the same domains as megf6a at 24 hpf, but it is also expressed in the developing somites (Supplemental Figure 1E) . The expression pattern of megf6b is maintained in the fin fold and head at 36 hpf and is also expressed in the AER of the pectoral fin and in the notochord (Supplemental Figure 1F) . Both megf6a and megf6b continue to be expressed in the notochord of 48 hpf larvae (data not shown). In the head of 48 hpf larvae, megf6b is expressed specifically in the mouth and pharyngeal region (Supplemental Figure 1G ). These data indicate that megf6a and megf6b have mostly overlapping expression domains during the first 48 hpf of development and are expressed in regions of the embryo that give rise to cartilage and bone.
To generate zebrafish lacking both megf6a and megf6b gene function, we first generated a germline deletion of megf6b. Both megf6a and megf6b are large genes containing 34 and 38 exons, respectively. To make a large deletion in megf6b, we injected CRISPR/Cas9 ribonucleoprotein (RNP) complexes targeting exons 6 and 35 into one-cell stage embryos (26).
We identified one allele, z48 -a 51,860 bp deletion with a 53 bp insertion, which stably transmitted through the germline (Supplemental Figure 2) . megf6b mutants are homozygous viable and the only overt phenotype is ectopic migration of a small number of melanocytes in the trunk and tail of 48 hpf larvae ( Figure 4A -B').
Paralogous genes in zebrafish can have redundant biological functions (27). As megf6a and megf6b are both expressed in the fin fold, head, and notochord, we hypothesized they might have partially redundant functions. Therefore, we generated embryos lacking both genes by injection of megf6b mutant embryos with CRISPR-Cas9 RNPs that disrupt megf6a function. Our previous work demonstrated this CRISPR approach completely eliminates function of the targeted gene in the injected embryo and generates F0 embryos that faithfully recapitulate loss-of-function mutants (26). We injected CRISPR-Cas9 RNPs targeting exons 6 and 28 of megf6a into one-cell stage embryos generated from an intercross between megf6b +/-adults, providing both control wildtype and megf6b mutant embryos that lacked megf6a function.
Whereas three-quarters of the intercross embryos appeared phenotypically wildtype following CRIPSR-Cas9 mutagenesis of megf6a ( Figure 4C ), roughly one-quarter of the larvae (21.7%, (n =115)) exhibited a severe disruption of the fin fold with aberrant migration of melanocytes into the fin fold area (Figure 4 D-F) . The aberrant embryos were genotyped, and all were found to be homozygous for the megf6b mutation, indicating that mutagenesis of megf6a only has measurable effect on fin fold development in the absence of megf6b function (p = 0.0056). These results indicate megf6a and megf6b have redundant functions during embryogenesis: loss of either gene had minimal effect on development whereas larvae lacking both megf6a and megf6b gene functions had severe defects on fin development.
Cartilage and bone form in an anterioposterior wave of development in the zebrafish larva, so that at any single time point posterior structures are developmentally younger than anterior ones.
Therefore, to examine cartilage and bone formation in the head and in the vertebral column, we analyzed mutant larvae at two developmentally distinct time points, 10 and 14 days post fertilization (dpf). To determine if megf6a and megf6b have a function in cartilage and bone development in the head, we analyzed 10 dpf larvae that developed from megf6b +/-intercross eggs injected with megf6a RNPs. Cartilage and bone formation were visualized after staining larvae with Alcian Blue (cartilage) and Alizarin Red (bone) (28). Injection of megf6a RNPs into WT or megf6b +/-larvae had no measurable effect on bone and cartilage formation ( Figure 5A and 5A'). However, twenty percent of the injected intercross larvae (n = 110) exhibited consistent delays in jaw development, including formation of the pharyngeal arches and development of both bones (5th ceratobranchyal (5CB) or cleithrum (CL)) and cartilaginous structures of the jaw ( Figure 5B and 5B'). Genotyping revealed that all the injected embryos with jaw defects were
megf6b -/-
, indicating that loss of both megf6 genes was required (p = 0.0062) to produce significant delays in jaw development.
Given that megf6a and megf6b have overlapping expression domains in the notochord (the embryonic version of the vertebral column) and that the two genes have overlapping functions in fin fold development ( Figure 4D -F), we analyzed the roles of the genes in bone and cartilage formation in the vertebral column and caudal fin of 14 dpf larvae. Progeny of a megf6b
intercross mating were injected with megf6a RNPs. Most larvae exhibited normal bone and cartilage formation in the vertebral column and caudal fin ( Figure 5C ). However, 17.5% of the larvae (n=80) exhibited a severe delay in the ossification of the posterior vertebrae and a delay in the formation of the cartilaginous structures and bony rays of the caudal fin ( Figure 5D -F). All the abnormal larvae proved to be megf6b -/-upon genotyping, indicating that only embryos lacking both megf6b and megf6a gene functions had an altered phenotype (p < 0.007). The functions of both genes are required for proper formation of both cartilaginous and bony structures in the zebrafish larvae.
To determine if zebrafish lacking megf6a and megf6b function have an adult phenotype, we separated 48 hpf larvae that developed from megf6b +/-intercross eggs injected with megf6a
RNPs (Figure 4 ) into two groups of 25 animals, those with normal fin folds (megf6b -/? ) and those with fin fold defects (megf6b
). Despite the developmental delay observed in doubly mutant larvae, 100% of the individuals of each group developed to adulthood. At 4 months of age, we measured the weight (g) and length (cm) of individual male and female adult zebrafish. The males in the abnormal fin fold group weighed less (mean ± SD -0.4098g ± 0.014g) than the males with normal fin folds (0.4556g ± 0.014g), while there was no significant difference in length between the two groups (abnormal fin folds -3.671cm ± 0.032cm vs normal fin folds -3.721cm ± 0.035cm). In contrast to the males, females in the abnormal fin fold group weighed more (abnormal fin folds -0.6616g ± 0.021g vs normal fin folds 0.5332g and ± 0.020g) and were longer (abnormal fin folds -3.971cm ± 0.035cm vs normal fin folds -3.809cm ± 0.034cm) than females with normal fin folds (Supplemental Figure 3) .
DISCUSSION
Whole exome sequence data from pairs of related osteoporosis-affected individuals from 10 extended high-risk pedigrees were analyzed to identify a small set of rare, IBD-shared variants representing excellent candidates responsible for osteoporosis predisposition in the pedigrees studied. A rare MEGF6 coding variant segregated with osteoporosis in the pedigree in which it was identified. In silico analyses of the predicted consequences of the amino acid substitution The design of the current study focused on exome sequencing of pairs of related affected individuals selected from extended high-risk pedigrees. Selection of subjects focused on affected cousins, which has been shown to be ideal when selecting subjects to represent dense pedigrees (29). The main benefit of the affected-relative-pairs strategy is efficiency with respect to data capture, but at the potential cost of missing evidence of disease variants that may have been detectable in a design that sequences all pedigree members. Here the strategy was sufficiently robust to lead to identification of at least one variant in ten pedigrees. The reliance on SGS analysis to delineate regions of long-range sharing between target pair members provided a productive filter of potential candidate variants. The use of well-sampled high-risk pedigrees has the added advantage of being able to invoke a test of segregation among additional affected family members to gain evidence of linkage to disease, which was shown here to be a particularly useful strategy for confirmation of the very rare variant rs755467862. emphasizing that correct folding of these domains is critical for molecular function (32).
Mutations in cbEGF-like domains that affect cysteine residues are likely to alter disulfide bond formation, which may disrupt correct folding (32). Furthermore, mutations affecting residues in the calcium binding consensus sequence reduce calcium binding affinity, which may lead to structural destabilization (32).
The biological roles of MEGF6 are not well understood. MEGF6 appears to be a secreted calcium binding protein that regulates cell migration through TGF-β/SMAD mediated epithelialmesenchymal transition (33). Depletion of MEGF6 caused reduction of TGF-β1 expression and phosphorylation of SMAD2 and SMAD3, whereas MEGF6 expression positively correlated with that of TGF-β1 expression, suggesting a role for MEGF6 in TGF-β/SMAD signaling. In osteoporosis, TGF-β is proposed to regulate osteoclastogenesis through activation of osteoprotegerin (OPG) (34) . OPG has been shown to inhibit the activity and survival of osteoclasts in vitro and bone resorption in vivo (23) . It is possible that reduced MEGF6 activity may alter TGF-β signaling and thus OPG expression, thereby contributing to osteoporosis.
Furthermore, we identified another potential link between MEGF6 and osteoporosis through a ZBTB40 -WNT16 interaction using the STRING database. Variants in ZBTB40 and WNT16
have been previously associated with osteoporosis (25, 35) and osteoblast-derived WNT16 inhibits osteoclastogenesis to prevent bone fragility (36) . Further studies are needed to determine if MEGF6 regulates TGF-β signaling in vivo and if it interacts with ZBTB40 or WNT16.
Our functional analyses demonstrate that the zebrafish orthologues of human MEGF6, megf6a
and megf6b, are together required for proper development and mineralization of both cartilage and bone in the head, vertebrae, and caudal fin. In the head of 10 dpf larvae, we observed a delay in the formation of the cartilaginous pharyngeal arches and a delay in mineralization of the 5th ceratobranchyal (5CB) and the cleithrum (CL) bones, while there was no defect in the initial mineralization of the notochord ( Figure 5A -B'). At 14 dpf there was a delay in the mineralization of the vertebral column and bones of the caudal fin, and a delay in the formation of cartilaginous structures of the caudal fin ( Figure 5C-F) . The mineralization of the 5CB, CL, and notochord (vertebral column) represent distinct modes of bone ossification: endochondral, membranous, and perichordal bone ossification, respectively. Given there is a delay in mineralization of all of these structures, megf6a and megf6b have important functions in the distinct modes of bone ossification.
The bone phenotype observed in larvae lacking megf6a and megf6b function is strikingly similar to several previously reported zebrafish mutant phenotypes. A mutation in the macrophagestimulating protein (msp) gene, or morpholino knockdown of its receptor, ron-2, display similar defects in the 5CB bone (37) . The msp mutant phenotype can be rescued by exogenous calcium supplementation to the media, indicating that Ron-2 and Msp are necessary for bone mineralization and calcium homeostasis (37) . The zebrafish Chihuahua (Chi) mutant disrupts col1a1a and is a model for classical osteogenesis imperfecta. Heterozygous Chi mutants have the same defects in the 5CB and CL bones and a delay in vertebral mineralization as are conspicuous in larvae with disrupted mefg6a and megf6b function (38) . The zebrafish frilly fins (frf) mutant disrupts the bmp1a gene and is phenotypically similar to the microwaved mutant, which carries another mutant allele of col1a1a (39) . BMP1 has a known function in the proteolytic processing of procollagen I C-propeptide to generate mature collagen type I (40), which may account for the phenotype similarities between the mutants. The frf mutant has a delay in the mineralization of the vertebrae reminiscent of larvae without megf6a and megf6b gene function (39) . Given the similarity of these mutant phenotypes and with the perspective that MEGF6 is a calcium binding protein, MEGF6 may have a role in regulating calcium homeostasis and collagen processing during embryonic development.
A Megf6-deficient mouse was recently reported with no discernable phenotype (41) . The apparent discrepancy between the mouse and zebrafish mutants may lay in the phenotypic analyses performed. There was no detailed histological analysis of embryonic skeletal development in the mouse, which may have overlooked subtle defects, and BMD was not analyzed in the adult. Skeletal phenotypes may be uncovered upon a more detailed analysis, since Megf6 is expressed in the mouse musculoskeletal system during development (42), during osteoblast differentiation, and in mature bone (43) . Furthermore, as the mouse mutation involved a coding alteration that resulted in no detectable Megf6 transcript (41), the mutant transcript likely underwent non-sense mediated decay and may have triggered genetic compensation mechanisms that masked the null phenotype (44, 45) .
Despite the dramatic developmental fin fold phenotype of megf6b -/-larvae injected with megf6a CRISPR/Cas9 reagents, adult zebrafish do not exhibit severe phenotypes (e.g., kyphosis), although there is a significant difference in the weight and length of these zebrafish. The adult males with abnormal fin folds weigh less than controls with normal fin folds without a reduction in overall length, which may reflect a loss in bone density. In contrast to the adult males, adult females with abnormal fin folds weigh more and are longer than controls with normal fin folds (Supplemental Figure 3) . This phenotype may be due to factors unique to the teleost lineage, including sex differences and compensatory growth mechanisms. Zebrafish grow in size throughout their lifetime and have prodigious regenerative capacities (46, 47) , which may contribute to the mild adult phenotype and the observed phenotypic differences between males and females. Further characterization of the zebrafish megf6a;6b mutant phenotype in aged adults and generation of zebrafish with the human disease allele (48) will provide insight into the genetic mechanisms of osteoporosis and may yield new targets for therapeutic intervention.
In sum, evidence of segregation, protein folding prediction, and in vivo functional evaluation support a role for MEGF6 in predisposition to development of osteoporosis.
MATERIALS AND METHODS
Utah osteoporosis pedigrees
Osteoporosis cases with a self-reported family history were ascertained and recruited from clinics associated with Intermountain Healthcare, the largest Utah health care provider, and local advertising in health care clinics; relatives of these cases were also recruited. All recruited individuals were offered a BMD scan for determination of osteoporosis phenotype. BMD was measured on a Hologic QDR 4500A fan-beam dual X-ray absorptiometry (DXA) bone densitometer by a single technician (49, 50) . Quality control for the DXA was performed daily on a spine phantom and all scans were reviewed and evaluated by a single experienced physician. BMD was measured at the hip and spine (or at the wrist if the hip or spine could not be imaged). In addition to the anteroposterior (AP) view of the spine, lateral measurements were taken. Scans were excluded if their interpretation was confounded by poor positioning or abnormal anatomy.
A total of 1,871 individuals were consented, phenotyped, and sampled in 276 multi-generational pedigrees with 4-46 sampled individuals per pedigree. In addition to BMD measurements, a single physician reviewed a subject medical history questionnaire, and available medical records to assign a phenotype of osteoporosis, osteopenia, unaffected, or unknown. Ten pedigrees were selected for sequencing based on a physician diagnosis of osteoporosis in a pair of (approximately) cousins (29), and having additional sampled affected relatives for tests of segregation. This study was approved by the Institutional Review Boards of Intermountain
Healthcare and the University of Utah.
Utah genomic data
Whole exome sequencing was performed on the 10 pairs of affected cousins at the Huntsman Cancer Institute's Genomics Core facility. DNA libraries were prepared from 3 micrograms of DNA using the Agilent SureSelect XT Human All Exon + UTR (v5) capture kit. Samples were run on the Illumina HiSeq 2000 instrument. Reads were mapped to the human genome GRCh37 reference using BWA-mem (51) for alignment and variants were called using Genome Analysis
Toolkit (GATK) (52) software following Broad Institute Best Practices Guidelines. Exome capture resulted in an average of 85% of target bases being covered by greater than 10x coverage across the genome. Variants occurring outside the exon capture kit intended area of coverage were removed. Variants were annotated with Annovar, which contains predicted pathogenicity scores from 10 in-silico functional prediction algorithms (11) . Samples were also genotyped on the Illumina OmniExpress high density SNP array (720,000 SNPs).
Candidate variant prioritization
Variants were filtered in four phases to achieve a small set of highly probable candidates. In the first phase, variants with population minor allele frequency (MAF) <0.005 that were observed in both index cases from a pedigree (affected cousins) were retained. In the second phase of variant filtration, the genomes of index pairs were restricted to regions exhibiting evidence of IBD transmission, or shared common ancestry. Focus on these IBD regions between sequenced cousin-pairs provides a useful filter that can rule out variants that are shared but were not inherited from a common ancestor and are inconsistent with a dominant mode of inheritance.
SNP genotypes were used to estimate regions of long shared haplotypes between related sequenced cases using SGS (8) . SGS analysis identifies the set of contiguous markers at which genotyped individuals could share alleles; long runs of such markers indicate likely regions of IBD sharing from a common ancestor (53) . Genomic regions were considered as IBD for a sequenced relative pair if the normalized shared-segment length was ≥20 standard deviations from the mean shared-segment length (54) . This selection criteria was based on the expected amount of IBD sharing that should occur for a pair of cousins (~12.5%), and provided an equivalent reduction to the genomic search space. The third phase of variant filtration required that the gene had at least one published study connecting the gene with osteoporosis through some genetic study design, identified via PubMed search (55) 
Confirmation of candidate variants via segregation to affected relatives
The 10 pedigrees of the sequenced relative pairs had a total of 68 additional sampled relatives, ranging from 4 to 15 per family. To confirm segregation of the candidate predisposition variants in the pedigrees, each variant was assayed in the sampled relatives of sequenced cases using custom Taqman assays (Applied Biosystems, Carlsbad, CA, USA) according to the manufacturer's specifications on a Bio-Rad CFX96 Real-Time PCR instrument. Evidence of segregation to additional affected relatives was evaluated with RVsharing software (9) that provides the probability of the observed configuration of sharing in a pedigree, expressed as an exact probability, assuming the shared variant is rare (<1%) and entered the pedigree only once.
Pathway analysis and protein structure prediction
The STRING database tool (21) with default settings was used to query a large number of known protein interactions concerning the candidate gene. Protein structure prediction software I-TASSER using full homology modeling was used to model the structure of critical domains assuming either wild-type or variant amino acid sequences (19, (56) (57) (58) . Predicted structures were visualized and analyzed using Chimera software (59) .
Zebrafish husbandry
Zebrafish (Danio rerio) were maintained in accordance with approved institutional protocols at the University of Utah. Adult zebrafish were maintained under standard conditions (60) and kept on a light-dark cycle of 14 hours in light and 10 hours in dark at 27°C. The Tu strain was used in all experiments.
megf6a and megf6b Mutant Generation
Mutations were generated with CRISPR-Cas9 reagents as described in (26). gRNA target sequences were as follows: megf6a exon 6 -CGCTGTCAGCATGGTGTTCT(TGG) and exon 28 -GCTCGCAGTGACCCTCTCAC(AGG); and megf6b exon 6 -AGCACACATGTGTGAACACT(AGG) and exon 35 -TCCTGTATCCGGATGACAGG(AGG). The PAM sequence is indicated in parentheses.
Target-specific Alt-R® crRNA and common Alt-R® tracrRNA were synthesized by IDT and dissolved in duplex buffer (IDT) as a 100μM stock solution. Equal volumes of the Alt-R® crRNA and Alt-R® tracrRNA stock solutions were mixed together and annealed in PCR machine using the following settings: 95°C, 5 min; cool at 0.1°C/sec to 25°C; 25°C, 5 min; 4°C.
Cas9 protein (Alt-R® S.p. Cas9 nuclease, v.3, IDT, dissolved in 20mM HEPES-NaOH (pH 7.5),
350mM KCl, 20% glycerol) and crRNA:tracrRNA duplex mixed to generate a 5μM gRNA:Cas9
RNP complex (referred to as RNPs). Prior to microinjection, the RNP complex solution was incubated at 37°C, 5 min and then placed at room temperature. Approximately one nano-liter of 5μM RNP complex was injected into the cytoplasm of one-cell stage embryos.
Genomic DNA extraction and genotyping
Genomic DNA was extracted from individual embryos at 24 hours post fertilization (hpf). 
In Situ Hybridization
Whole mount in situ hybridization (WISH) was performed on embryos as described in (62) .
cDNA fragments used to generate riboprobes probes were amplified by RT-PCR using the following primers: megf6a ISH F -TGGCACCTGCAGCTGCCC, and megf6a ISH R -TCCAGCCGTTCAGACACGTGCA, or megf6b ISH F -TGAACAGACGTGTCCGCAGGG, and megf6b ISH R -TCACACTCGCACAGCAGAGAGC using KAPA 2G FAST Master Mix, sub-cloned into pGEM-T Easy, and subjected to Sanger sequencing for verification.
Cartilage and Bone Staining
Ten and 14 dpf zebrafish larvae were anesthetized with Tricaine methanesulfonate (ethyl 3-aminobenzoate methanesulfonate) and processed as described in (28) 
Length and Weight Measurements
One-cell stage embryos from an intercross between megf6b +/-adults were injected with megf6a
RNPs and larvae were sorted at 48 hpf into two groups of 25 animals, those with normal fin folds (megf6b -/? ) and those with fin fold defects (megf6b
). Animals were raised to 4 months of age.
At 4 months of age adults were anesthetized using Tricaine methanesulfonate and the length (cm) of each zebrafish was determined by measuring from the anterior most portion of the head to the tip of the tail. Zebrafish were then weighed and allowed to recover from anesthesia.
Statistical analysis
RNPs and larvae were sorted at 48 hpf based on whether or not they displayed the mutant fin fold phenotype. Embryos were then genotyped as describe above. For the cartilage and bone analysis, embryos were stained, sorted based on phenotype, and then genotyped. To determine whether phenotypically defective larvae were significantly enriched for the megf6b -/-genotype,
Fisher's exact test with Bonferroni correction was used to determine statistical significance. A Student's t-test was used to determine statistical significance for the weight and length comparisons. Hu, H., Wang, M., Wang, H., Liu, Z., Guan, X., Yang, R., Huang, R., Tang, Q., Zou, C., Wang, G. et al. 
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